
        <!DOCTYPE html>
        <html>
        <head>
            <title>Biogen Inc. (BIIB) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Biogen Inc. (BIIB)</h1>
                    <a href="index.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">51</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">29</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">10</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.22</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d" target="_blank" rel="noopener noreferrer">Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-05</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c612a80aa45d7b0fc1b6c79ce2ccd4a380a4c6028b7814d53a8af1b32b43d3d8" target="_blank" rel="noopener noreferrer">C4 Therapeutics Highlights Recent Achievement in Biogen Collaboration</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.84
                                </span>
                            </div>
                            <div class="article-summary">Development Candidate Targeting IRAK4 Now Progressing Toward Clinical DevelopmentWATERTOWN, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage bioph...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=99672322321f5ad7113e1732e7950765b7f5315f214960c660855ee44ee12fc3" target="_blank" rel="noopener noreferrer">Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Value investing subreddit by Significant-Foot3928. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmac...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e4018b65febe0fd98181b8c06144f112450136f2dd9e7e406b84afd24cf758a7" target="_blank" rel="noopener noreferrer">Biogen (BIIB) Stock Trades Down, Here Is Why</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.79
                                </span>
                            </div>
                            <div class="article-summary">Shares of biotech company Biogen (NASDAQ:BIIB) fell 3% in the afternoon session after Needham analyst Ami Fadia reiterated a "Hold" rating on the stock. This rating suggests the analyst expects the st...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7c6b2d2a5f1a5847de2a79a6034a2f8d74759a8a5dbbd8fa97980e338ec71921" target="_blank" rel="noopener noreferrer">Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.26
                                </span>
                            </div>
                            <div class="article-summary">LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start to help patients and care partners treat this progressive...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=52ef569613fe74c7d1b6d21e936287207807b12bf549f063cddc954028f0e13a" target="_blank" rel="noopener noreferrer">Startup Corsera Health aims to bring preventive heart medicine to the masses</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Co-founded by RNA interference pioneer John Maraganore and former Medicines Company head Clive Meanwell, Corsera Health is developing diagnostic tools and medicines for heart health....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a5bcec5d861c22843678fe358c8654480cd407f7128a469c4051a1f11146e65a" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.70
                                </span>
                            </div>
                            <div class="article-summary">We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Biogen Inc. is one of them. Biogen Inc. (NASDAQ:BIIB), founded in 1978 and headquartered in Cambridge, Mass...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d188e9fb589f7c9881b8b2761f7fca85540a10a2c52b49617fc9682b7b091db8" target="_blank" rel="noopener noreferrer">These Stocks Are Moving the Most Today: Nvidia, NIO, Biogen, Newmont, Corning, and More</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.38
                                </span>
                            </div>
                            <div class="article-summary">Nvidia declines, NIO rises after the release of second-quarter earnings, and Biogen trades higher after the Food and Drug Administration approves a once-weekly injectable version of Alzheimer’s treatm...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fc080cb988c8093e62ead6058cfb6e42b81fdf23a34de66d8ba5d30722a0c460" target="_blank" rel="noopener noreferrer">Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.76
                                </span>
                            </div>
                            <div class="article-summary">BEDFORD, Mass. & CAMBRIDGE, Mass., September 02, 2025--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential wit...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7b95346aa74815f430e0131b6375f41e2fc1f3ebd5c731b56bb91bc68ea5c1c8" target="_blank" rel="noopener noreferrer">Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">– Durable reductions in seizures and continuing improvements in cognition and behavior through 3 years in patients who continued to receive zorevunersen in the open-label extension studies – – Substan...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=dc583b6f8e59ac5179a804f53579185d7c9bc4927208b2e17bb4197fb15c486a" target="_blank" rel="noopener noreferrer">Amgen to invest $600M in new US center; Sanofi drug for ITP approved</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.58
                                </span>
                            </div>
                            <div class="article-summary">The new "science and innovation center" will be built at Amgen's headquarters in Thousand Oaks, California. Elsewhere, Wayrilz became the first BTK blocker cleared for immune thrombocytopenia....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bc8fead22d6ece91361a69aaa7b25830a0dd3ec121a87a8a0caa9fd2c27163d5" target="_blank" rel="noopener noreferrer">Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Effective September 1, 2025 Denis Johnson, CEO Denis Johnson, CEO, Grand River Aseptic Manufacturing Grand Rapids, Michigan, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Grand River Aseptic Manufacturing (“GRAM...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cf8e5bcfe206d93fc6364a5a79d3aaaa490382601b419d9ed1a520050831b663" target="_blank" rel="noopener noreferrer">US Equity Indexes Slump, Volatility Spikes Amid Gains in Treasury Yields</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.96
                                </span>
                            </div>
                            <div class="article-summary">US equity indexes headed lower after midday on Tuesday amid a sharp move higher in government bond y...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=40a79ce56f51227aee452da07051b8dbe451a3bdc02f77ffab5b1b9fe99be32b" target="_blank" rel="noopener noreferrer">Biogen (BIIB) Stock Is Up, What You Need To Know</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Shares of biotech company Biogen (NASDAQ:BIIB) jumped 4.8% in the afternoon session after the company and its partner Eisai received FDA approval for a weekly subcutaneous injection of their Alzheimer...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=29b049d019538949f406d4c5f0b61522fe538d2126f47701ceccd03ae7788c86" target="_blank" rel="noopener noreferrer">/U P D A T E -- Eisai Inc./</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.42
                                </span>
                            </div>
                            <div class="article-summary">Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that t...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=93f6ed1a593cdf9a6334047072bd6a0bed1d3f109e70146b7406830555d0c132" target="_blank" rel="noopener noreferrer">US Equity Markets End Lower Following Court Ruling Against Trump Tariffs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.95
                                </span>
                            </div>
                            <div class="article-summary">US benchmark equity indexes ended lower on Tuesday as investors considered the impacts of a federal...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c2154a3dd0de5cb40c3763ff6de6ad19725e2a91d03e8cebcd53aaf773f82c6e" target="_blank" rel="noopener noreferrer">US Equity Indexes Decline as Gains in Treasury Yields Push Mag-7 Lower</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.95
                                </span>
                            </div>
                            <div class="article-summary">US equity indexes retreated Tuesday as the so-called Magnificent-7 stocks declined amid gains in gov...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5fcb22efe784c3c1bc1390055a3abba44f55bffbec9fbdb7de18c979e53736ab" target="_blank" rel="noopener noreferrer">Biogen Secures FDA Nod for Subcutaneous Maintenance Dosing of Leqembi</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">BIIB wins FDA approval for Leqembi Iqlik, a fast, subcutaneous option for early Alzheimer's patients transitioning from IV infusions....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=59e87c964602bcc8bccce301c15d9e6109a1550b0ffefc9f8e0a17563c32f3d9" target="_blank" rel="noopener noreferrer">FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.76
                                </span>
                            </div>
                            <div class="article-summary">Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that t...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8ac325eaebc6ca62bbd8cd12edd6a0b694688f2cd3f5b93dc6f505b44671057d" target="_blank" rel="noopener noreferrer">FDA Approves Biogen, Eisai's Highly Anticipated Alzheimer's Treatment</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.87
                                </span>
                            </div>
                            <div class="article-summary">Biogen and Eisai won Food and Drug Administration approval of an at-home shot version of their Alzheimer's treatment Leqembi....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8bcdf440d667fc7d5cb8af92d9cbe31d149794a4057100d7b8d2c3eefea3710b" target="_blank" rel="noopener noreferrer">Leqembi Or Blarcamesine For Alzheimer's Disease: Which One Is Better</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-26</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Anavex's Blarcamesine shows promise vs. Leqembi with better safety and ease....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f589be1dc667f9be6687c7760da76c672078c070207881a906361c507bc6e319" target="_blank" rel="noopener noreferrer">Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.22
                                </span>
                            </div>
                            <div class="article-summary">TOKYO and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massach...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=81db572aae98abda9363ac6d61315a28ef55390217c2a115a4c4a259a0b8824c" target="_blank" rel="noopener noreferrer">Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">– 3-year data from open-label extension (OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on top of standard a...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a72e52561a2dc76d1f2eb132bb71482ad08afdf273dec72b2af61c8dbc49d69a" target="_blank" rel="noopener noreferrer">Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">BEDFORD, Mass. & CAMBRIDGE, Mass., August 25, 2025--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with R...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f27c12d42fdcd7d18ca65a8c1ddf3f68baa4f282f4e98209e316c6f95a687efc" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Monday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Monday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9c17ae8c9528dd507c63d5fb6ccada559a31229c331d4acbe56b7596a5ce8027" target="_blank" rel="noopener noreferrer">Biogen Stock: Analyst Estimates & Ratings</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.48
                                </span>
                            </div>
                            <div class="article-summary">Biogen has lagged the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on the stock’s future performance....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9aaef2be70e1f2d712f1b47c8b1dce64987548f13e4fff641e2d6a7b53569d78" target="_blank" rel="noopener noreferrer">[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Biologics and Biosimilars Market size & share revenue was valued at a...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=de7cc61f7b72090da27c6cd7ed9b7dc24254cb04a039676a0ff2530bb367244a" target="_blank" rel="noopener noreferrer">Alzheimer's Disease: When All Else Fails</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Most candidates fail to show meaningful clinical benefit in Alzheimer's. Read why I am against investing in companies based solely on their Alzheimer's drug programs....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=10044eb56e5bac105636b96a9d8beaff526555f515821f6fdfc9c86d42fc33ab" target="_blank" rel="noopener noreferrer">2 Cash-Producing Stocks with Exciting Potential and 1 We Ignore</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.57
                                </span>
                            </div>
                            <div class="article-summary">While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competit...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5e1079b6f40e56f485ff1e228dafd1ac7bfd721de9162c10b2eca1ef1b7a20d7" target="_blank" rel="noopener noreferrer">eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">CAMBRIDGE, Mass., August 19, 2025--eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=12ba64d8e1a5c399e8a26fde30baff11f534c2c2181e327272d8e72cdc183fa4" target="_blank" rel="noopener noreferrer">Biogen Inc. stock outperforms competitors on strong trading day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock outperforms competitors on strong trading day...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b57b95b5e257a8ed46801de29067791825d1741aca966e61fe13f39ff05d5c56" target="_blank" rel="noopener noreferrer">[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approxima...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6973171bd0cf52d82f3f84b27d25a871dd5a8b2b7f2552aca2e361a691e8f8a8" target="_blank" rel="noopener noreferrer">5 Revealing Analyst Questions From Biogen’s Q2 Earnings Call</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Biogen’s second quarter delivered results that exceeded Wall Street’s revenue and profit expectations, a performance that was met with a positive market reaction. Management highlighted continued grow...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d3ed26fb2712d0634ee34cd1a3a8cd7f9a61df59c170fa5d10cadf71ccbb13df" target="_blank" rel="noopener noreferrer">BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Biotech company Biogen (NASDAQ:BIIB) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.3% year on year to $2.65 billion. Its non-GAAP profit of $5.47 per share was 41.3% above anal...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=322994fed4b380affd85d4b7193b9748e1030b15403e7ae7be9e65c46df69764" target="_blank" rel="noopener noreferrer">Scholar Rock Holding: Upcoming Milestone Approaches</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">With a market cap of $3.1 billion, Scholar Rock Holding Corporation appears fairly valued for now. Click here to read an analysis of SRRK stock now....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f748b6a3dc571de13eb1fedaabf19603761a479b602748cb464eeb611f0c9cde" target="_blank" rel="noopener noreferrer">Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.31
                                </span>
                            </div>
                            <div class="article-summary">A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Pr...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=84c3c8397fd408ef0ee389434f7fda91e32406726d3f0117d016d2c79c0aca64" target="_blank" rel="noopener noreferrer">First patient dosed in Phase III trial of zorevunersen for Dravet syndrome</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.49
                                </span>
                            </div>
                            <div class="article-summary">The study will assess the efficacy and safety of zorevunersen compared to sham over a 52-week treatment period....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d1d4a3c8f36f6f1ad180dc4303d28b035a217c44f0c0db2f6f6857488a4abe18" target="_blank" rel="noopener noreferrer">New .med Domain Names Surpass 40,000 Pre-Orders in July</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.75
                                </span>
                            </div>
                            <div class="article-summary">With consumers struggling to differentiate between credible and unreliable medical information online, Medistry LLC's premium .med Top Level Domain (TLD) is poised to help....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=44898670113173f3eb11866417ec12fa9fc2e67d687993d71e9d0fda80d82bb4" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Advance in Afternoon Trading</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.86
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Health Ca...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9deb48a3b391d5a6975b76a8df57daff12c33f3652ba44ad11599bbf43d26ea9" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Rise Late Afternoon</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.86
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks were higher late Tuesday afternoon, with the NYSE Health Care Index and the Healt...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4a6b161a97e65ce1a4b104f66d2e62e059f1d1b958b21ca5e5226e3e45801fc7" target="_blank" rel="noopener noreferrer">Gilead Stock Is Closing In on an All-Time High. The Case for More Upside.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.78
                                </span>
                            </div>
                            <div class="article-summary">While Celgene was absorbed by  Bristol Myers  in early 2019,  Gilead Sciences  has emerged as the enduring standout among the remaining trio.  Gilead has surged 59% and offers a healthy 2.6% dividend ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=93bac2fffa27ededc8bd751bb6ba8223840552fe849d03631f0fbd42d95bac1d" target="_blank" rel="noopener noreferrer">Gilead Sciences Is Closing In on an All-Time High. The Case for More Upside.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.82
                                </span>
                            </div>
                            <div class="article-summary">While Celgene was absorbed by  Bristol Myers  in early 2019,  Gilead Sciences  has emerged as the enduring standout among the remaining trio.  Gilead has surged 59% and offers a healthy 2.6% dividend ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=59d34aff570a51957d49ab370795dd4b8774689358da1f42bfc8b9809a1923ba" target="_blank" rel="noopener noreferrer">Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 | Distribution Channel, Route of Administration, and Region Analysis and Forecast to 2035</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.46
                                </span>
                            </div>
                            <div class="article-summary">Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder targeting the peripheral nervous system, causing muscle weakness and sensory issues. Often considered the chronic...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=afa82ba6bb4a5a3fbde9fb43fa9238cb6aef88050ffbdb8728ac0e7b55298cc0" target="_blank" rel="noopener noreferrer">Stoke Therapeutics and Biogen Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.60
                                </span>
                            </div>
                            <div class="article-summary">BEDFORD, Mass., & CAMBRIDGE, Mass., August 11, 2025--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f4302736e134d312db861ee6a42413e3c15b1a6f3c006c01855f4df08bd69d95" target="_blank" rel="noopener noreferrer">Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.23
                                </span>
                            </div>
                            <div class="article-summary">– Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment period – – Dravet syndrome is a rare genetic disease characterized by refrac...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=534337382586b46f9ea2f8c1c5acc29450adc535e42615067428c75ff2a6bf7e" target="_blank" rel="noopener noreferrer">Biogen, Stoke Therapeutics Dose First Patient in Phase 3 Trial of Zorevunersen for Dravet Syndrome</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen (BIIB) and Stoke Therapeutics (STOK) said Monday they have dosed a first participant in a pha...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e818c7ab040c6d6faecea6bdeee9326ce5f2a80ffa7e326f236e15f379470703" target="_blank" rel="noopener noreferrer">3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.80
                                </span>
                            </div>
                            <div class="article-summary">Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=57255d980f4da737750a4c15fff79c3d38b351ed8ad171479891927207455058" target="_blank" rel="noopener noreferrer">We Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can Achieve</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NasdaqGS:BIIB 1 Year Share Price vs Fair Value Explore Biogen's Fair Values from the Community and select yours Biogen......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6dde105958fe560ebdb5c8e3d41004d62882fe8e2a662ef3af62754c7884e26e" target="_blank" rel="noopener noreferrer">Eli Lilly And Biogen (And Eisai): Muddying The Waters In Alzheimer's Disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=808f5794e22062ad585b459a7278627950defff4d48397f82f8daf979de68d97" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Thursday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Thursday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=41d933ce123460804f2b1273cea3c1b557443880f5774debe087506fc6209ca0" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Wednesday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.91
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Wednesday when compared to competitors...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        